PMC:7195088 / 67202-68210
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1952 | 255-263 | Species | denotes | patients | Tax:9606 |
1953 | 311-319 | Species | denotes | patients | Tax:9606 |
1954 | 740-748 | Species | denotes | patients | Tax:9606 |
1955 | 935-943 | Species | denotes | patients | Tax:9606 |
1956 | 956-964 | Species | denotes | patients | Tax:9606 |
1957 | 20-31 | Chemical | denotes | chloroquine | MESH:D002738 |
1958 | 32-50 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
1959 | 438-456 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
1960 | 617-624 | Chemical | denotes | steroid | MESH:D013256 |
1961 | 828-835 | Chemical | denotes | steroid | MESH:D013256 |
1962 | 275-301 | Disease | denotes | respiratory tract symptoms | MESH:D012140 |
1963 | 331-357 | Disease | denotes | respiratory tract symptoms | MESH:D012140 |
1964 | 715-729 | Disease | denotes | critically ill | MESH:D016638 |
1965 | 735-739 | Disease | denotes | ARDS | MESH:D012128 |
1966 | 930-934 | Disease | denotes | ARDS | MESH:D012128 |
1967 | 951-955 | Disease | denotes | ARDS | MESH:D012128 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T116 | 269-292 | Body_part | denotes | upper respiratory tract | http://purl.org/sig/ont/fma/fma45661 |
T117 | 325-348 | Body_part | denotes | lower respiratory tract | http://purl.org/sig/ont/fma/fma45662 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T51 | 269-292 | Body_part | denotes | upper respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001557 |
T52 | 275-292 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T53 | 325-348 | Body_part | denotes | lower respiratory tract | http://purl.obolibrary.org/obo/UBERON_0001558 |
T54 | 331-348 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T383 | 735-739 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T384 | 930-934 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T385 | 951-955 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T369 | 166-171 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T370 | 210-212 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
T371 | 230-231 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T372 | 325-348 | http://purl.obolibrary.org/obo/UBERON_0001558 | denotes | lower respiratory tract |
T373 | 411-412 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T374 | 670-671 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T375 | 783-784 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T87596 | 20-31 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T51549 | 32-50 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T54232 | 55-70 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T33985 | 238-243 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T99 | 438-456 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T38634 | 617-624 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T95699 | 828-835 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T473 | 0-104 | Sentence | denotes | The optimal time of chloroquine/hydroxychloroquine and corticosteroids initiation still remains unknown. |
T474 | 105-601 | Sentence | denotes | Although based on low-level evidence, the positive effect of virus clearance observed by Gautret et al. [41] was observed in a mixed group of non-ICU patients with upper respiratory tract symptoms, non-ICU patients with lower respiratory tract symptoms and asymptomatic subjects, which overall may support a positive effect of early hydroxychloroquine initiation in non-ICU settings (although information on the exact time of treatment initiation with respect to symptoms onset was not provided). |
T475 | 602-749 | Sentence | denotes | With regard to steroid treatment, there is currently no evidence of a positive impact of early initiation in non–critically ill, non-ARDS patients. |
T476 | 750-1008 | Sentence | denotes | Although lack of evidence is not a synonym of lack of effect, in our opinion, steroid treatment, considering also its potential detrimental effects, should currently be limited to ARDS patients or non-ARDS patients with worsening conditions (see question 5). |